Suppr超能文献

全国范围内普通人群对人乳头瘤病毒疫苗的知识、态度和实践的上市后调查:对中国大陆疫苗推广的启示。

A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China.

机构信息

Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Institute for Expanded Program on Immunization, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, China.

出版信息

Vaccine. 2021 Jan 3;39(1):35-44. doi: 10.1016/j.vaccine.2020.11.029. Epub 2020 Nov 23.

Abstract

BACKGROUND

Human papillomavirus (HPV) vaccine has been increasingly discussed in mainland China since its first approval in 2016. To date, nearly all studies assessing HPV vaccine perceptions and attitudes were implemented during pre-licensure period. Therefore, the nationwide post-marketing survey was conducted to update knowledge, attitudes and practice on HPV vaccine among general population in mainland China.

METHODS

Participants aged 18-45 years living in mainland China were recruited in April 2019 by multi-stage non-randomized sampling. Sociodemographic factors, HPV and HPV vaccine related awareness, knowledge, attitudes, vaccine uptake and potential obstacles were assessed in questionnaires. Bivariate analysis and multivariate regression were used to identify disparity among subgroups with different sociodemographic characteristics.

RESULTS

4,000 women (32.1 ± 7.81y) and 1,000 men (31.8 ± 7.96y) were included in final analysis. Less than one third of participants had heard of HPV (female: 31%; male: 22%) and HPV vaccine (female: 34%; male: 23%). Knowledge score was also unfavorable on HPV (female: 3 out of 13; male: 1.8 out of 13) and HPV vaccine (female: 3 out of 6; male: 2 out of 5). Only 3% females had been vaccinated three years after HPV licensure in China, although willingness to get vaccinated among those unvaccinated were high (mean willingness score ± SD: female: 3.3 ± 0.97; male: 3.0 ± 0.98). Industry of employment and household income were the major factors related to awareness and knowledge of vaccine, whereas HPV and HPV vaccine awareness were key influential factors for willingness. The main obstacles of vaccination were safety concerns, lack of knowledge, and high price of HPV vaccines.

CONCLUSIONS

Findings highlight a lack of vaccine awareness, knowledge, and poor uptake in mainland China and underscore the necessity of health education campaigns. The identified priority groups, contents to be delivered and practical obstacles could furthermore provide insight into health education to reduce disparities and accelerate HPV vaccine roll-out in China.

摘要

背景

自 2016 年首次批准以来,人乳头瘤病毒(HPV)疫苗在中国内地越来越受到关注。迄今为止,几乎所有评估 HPV 疫苗认知和态度的研究都是在许可前进行的。因此,进行了全国性的上市后调查,以更新中国内地普通人群对 HPV 疫苗的认知、态度和实践。

方法

2019 年 4 月,采用多阶段非随机抽样的方法,招募了年龄在 18-45 岁之间的中国内地居民作为参与者。通过问卷评估社会人口统计学因素、HPV 和 HPV 疫苗相关认知、知识、态度、疫苗接种情况以及潜在障碍。采用单变量分析和多变量回归来确定不同社会人口统计学特征亚组之间的差异。

结果

最终分析纳入了 4000 名女性(32.1±7.81 岁)和 1000 名男性(31.8±7.96 岁)。不到三分之一的参与者听说过 HPV(女性:31%;男性:22%)和 HPV 疫苗(女性:34%;男性:23%)。在 HPV(女性:13 题中答对 3 题;男性:13 题中答对 1.8 题)和 HPV 疫苗(女性:6 题中答对 3 题;男性:5 题中答对 2 题)方面,知识得分也不理想。尽管未接种疫苗的人群中有很高的接种意愿(平均接种意愿得分±SD:女性:3.3±0.97;男性:3.0±0.98),但自中国 HPV 疫苗获得许可以来,仅有 3%的女性接种了三针。就业行业和家庭收入是与疫苗认知和知识相关的主要因素,而 HPV 和 HPV 疫苗的认知是意愿的关键影响因素。接种疫苗的主要障碍是安全性担忧、缺乏知识和 HPV 疫苗价格高。

结论

研究结果表明,中国内地疫苗认知、知识水平较低,疫苗接种率低,这突显了开展健康教育运动的必要性。确定的重点人群、要传递的内容和实际障碍可以进一步为健康教育提供信息,以减少差异,加速 HPV 疫苗在中国的推广。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验